Labshake search
Citations for R&D Systems :
1 - 50 of 1759 citations for Integrin alpha 4 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2020Quote: ... human integrin alpha V/CD51 antibody (R&D Systems), mouse vinculin hVIN-1 (Sigma-Aldrich ...
-
bioRxiv - Developmental Biology 2021Quote: ... biotinylated to antibodies for Integrin alpha 8 (Itgα8, R&D Systems AF4076) using the DSB-X Biotin Protein Labeling Kit (ThermoFisher D-20655) ...
-
bioRxiv - Cell Biology 2021Quote: Recombinant human αVβ3 integrins (R&D Systems, #3050-AV-050) were reconstituted in 20 mM Tris buffered saline (TBS) ...
-
bioRxiv - Biochemistry 2022Quote: ... 2 µg of recombinant Mac-1 integrin (R&D systems) was incubated with reduced PDI or enzymatically inactive PDI at 10 µM for 30 min at 25°C ...
-
bioRxiv - Cell Biology 2023Quote: ... mouse Integrin alpha 7 Alexa Fluor 750-conjugated Antibody (FAB3518S, R&D Systems), APC anti-mouse CD45 Antibody (103111 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant Human Interferon alpha 2a (IFN-alpha) was purchased from R&D systems. Cisplatin was purchased from Sigma-Aldrich.
-
bioRxiv - Bioengineering 2020Quote: ... Recombinant human α5β1 and αVβ3 integrins (R&D Systems Bio-Tech) (100 µg/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Cell Biology 2020Quote: ... SCs were sorted based on positive alpha 7-integrin (1:100, R&D Systems FAB3518P) and absence of Sca1 (1:1000 ...
-
bioRxiv - Cell Biology 2023Quote: ... positive selection marker: Mouse anti-integrin alpha 7 Alexa fluor 647 (FAB3518R, R&D Systems). Cells were rinsed ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant Human TNF-alpha Protein purchased from R&D Systems was diluted in 1X Dulbecco’s phosphate buffered saline (DPBS ...
-
bioRxiv - Physiology 2020Quote: Recombinant human Mfge8 and recombinant human laminin subunit alpha-1 were purchased from R&D Systems, www.rndsystems.com ...
-
bioRxiv - Immunology 2022Quote: Recombinant Mouse IL-15R alpha Fc Chimera Protein (R&D Systems) and recombinant Mouse IL-15 (Tonbo Biosciences ...
-
bioRxiv - Cancer Biology 2023Quote: Antibodies used for FACS: Human/mouse/bovine integrin alpha 6/CD49f PE-conjugated antibody (FAB13501P, R&D Systems); PE/Cyanine 7 anti-mouse CD325 (Ep-CAM ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant Mouse Interferon Alpha-A (IFNα, R&D Systems, Inc. Minneapolis, MN) was administered either intratumorally or intramuscularly ...
-
bioRxiv - Developmental Biology 2022Quote: ... ITGA8 was stained by the use of polyclonal goat anti-Integrin alpha 8 antibody (1:50; R&D Systems, Minneapolis) and GDNF was stained by the use of polyclonal rabbit anti-GDNF antibody (1:100 ...
-
Microbial signals and lymphotoxin drive TNF-independent death of A20 and ABIN-1 deficient epitheliumbioRxiv - Immunology 2021Quote: ... a recombinant mouse lymphotoxin alpha ELISA reference (a gift from R&D systems), peroxidase streptavidin (Jackson ImmunoResearch) ...
-
bioRxiv - Cell Biology 2023Quote: ... mouse/rabbit Integrin β1 goat pAb (1:1000, AF2405, R&D Systems) and GAPDH rabbit mAb (1:2000 ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human interleukin 4 (IL-4) (R&D Systems), Alpha MEM with nucleosides (StemCell Technologies ...
-
bioRxiv - Immunology 2022Quote: ... were coated with 100 μl per well of 1.5 μg/ml human recombinant integrin αvβ6 (R&D Systems) diluted in coating buffer from the ELISA Starter Accessory Kit (Bethyl Laboratories ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Biophysics 2023Quote: ... and then a binding buffer solution containing 200 nM of recombinant αVβ5 human integrin extracellular domains (R&D Systems) was slowly added to one of the wells of the fluid chamber ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 10 mU recombinant DPP-4 (R&D Systems), or no enzyme as a control for non-enzymatic degradation over the same time period ...
-
bioRxiv - Pathology 2021Quote: A total of 50 μL/well of recombinant human IL5-Receptor alpha (R&D Systems, Minneapolis, MN) final concentration of (4 μg/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Immunology 2021Quote: Recombinant CSF-1 (4 µg/dose; R&D Systems) was given to EAE mice on days 4 ...
-
bioRxiv - Cancer Biology 2020Quote: ... crossed into the outbred CD1 background to permit post-natal survival were immunized with recombinant αvβ8 integrin (R&D Systems, 4135-AV-050) 50μg per mouse every two weeks ...
-
bioRxiv - Genetics 2022Quote: ... anti-α3 integrin (R&D Systems, AF2787), 1 µg/mL ...
-
bioRxiv - Genetics 2022Quote: ... anti-α9 integrin (R&D Systems, AF3827), 1 µg/mL ...
-
bioRxiv - Biophysics 2020Quote: Recombinant human ADAMTS-4 (R&D Systems, Minneapolis, MN, USA) and MMP-13 (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/ml recombinant murine IL-4 (R&D Systems), and 5 ng/ml recombinant human TGF-β (R&D Systems) ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant syndecan-4 (R&D Systems Cat# 6267-SD-050) and recombinant syndecan-2 (R&D Systems Cat#6585-SD-050) ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant 52-kDa pro-cath-D (4 µM; R&D Systems) was auto-activated to 51-kDa pseudo-cath-D in 0.1 M Na-acetate buffer (pH 3.5) ...
-
bioRxiv - Developmental Biology 2019Quote: ... 4 ng human recombinant IGF2 (292-G2-050, R&D Systems) was used as positive control ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Cell Biology 2024Quote: ... 20 ng/ml recombinant mouse interleukin-4 (IL-4) (R&D Systems, Cat number: 404-ML) was used (25) ...
-
bioRxiv - Neuroscience 2022Quote: ... 506-RL-010/CF) and carrier free Recombinant Mouse TNF-alpha (aa 80-235) Protein (410-MT-025/CF) purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Cell Biology 2024Quote: ... and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Immunology 2020Quote: ... or Integrin α1β1 inhibitor Obtusatin (10nM, R&D Systems) in the coated culture plate ...
-
bioRxiv - Developmental Biology 2022Quote: ... mouse integrin alpha9 (AF3827, R&D Systems, 1:200), Sox2 monoclonal antibody ...
-
bioRxiv - Cell Biology 2023Quote: ... and α7-integrin (R&D Systems, #FAB3518N, 1/30). Myf5 subpopulations identified as Pax7-ZsGreen1 positive and Myf5-E2Crimson high or low were isolated using a Beckman Coulter Astrios Cell sorter.
-
bioRxiv - Biochemistry 2022Quote: ... anti-ERAP2 (mAb clone 3F5, MAB 3830 R&D Systems) (25) ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Cell Biology 2020Quote: A separate experiment employed the culture and counting methods described above for irisin treatment in combination with a neutralizing antibody for integrin αVβ5 (Anti-Integrin aVb5, MilliporeSigma, Burlington, MA, USA) and an IgG control (Mouse IgG1 Isotype Control, R&D Systems, Minneapolis, MN, USA), each supplied continuously in the media during the 7 day culture at 0.9 µg/ml.